Non-opioid meds for addiction treatment remain key unmet need

Opioid Use Disorder (OUD) is a chronic neurological disorder that is described as the consequences associated with repeated, compulsive use of opioid drugs and prolonged self-administration of opioid drugs.

In August 2024, 110 high-prescribing psychiatrists, addiction specialists, neurologists, and primary care physicians from eight major markets (8MM: USA, France, Germany, Italy, Spain, UK, Australia, and Canada) were surveyed by pharma analytics firm GlobalData on the key unmet needs in treatment of OUD.

Non-opioid medications that treat addiction and withdrawal, and drugs with improved safety and tolerability profiles were consistently ranked by respondents as the most important unmet needs in the OUD market (ranking from 1 to 9, where 1 indicated the most significant need and 9 the least important). This trend was seen throughout the 8MM, according to the leading data and analytics company.